1-10 of 10
Fei Wan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prognostic Significance of Clinical Characteristics and Baseline PET-CT Metabolic Parameters in Patients with Marginal Zone Lymphoma

Imran A. Nizamuddin, Adeel Haq, Fei Wan, Marcus P. Watkins, Lauren Kelly Shea, Nancy L. Bartlett, Brad S. Kahl, Joyce Mhlanga, Neha Mehta-Shah
Journal: Blood
Blood (2024) 144 (Supplement 1): 6334.
https://doi.org/10.1182/blood-2024-204458
Published: 2024
Journal Articles

Mosunetuzumab Plus Polatuzumab Vedotin Induces Early Complete Responses in Previously Untreated High Tumor Burden Follicular Lymphoma

David A Russler-Germain, Fei Wan, Emily R. King, Chaz Moreno, Michelle Becker-Hapak, Patrick Pence, Joseph Rueve, Sushanth A Pureti, Dilan A. Patel, Brad S. Kahl, Neha Mehta-Shah, Todd A Fehniger, Nancy L. Bartlett
Journal: Blood
Blood (2024) 144 (Supplement 1): 4414.
https://doi.org/10.1182/blood-2024-202085
Published: 2024
Journal Articles

Phase I Results of Acalabrutinib in Combination with Durvalumab in Primary Central Nervous System Lymphoma: Safety, Efficacy, and Central Nervous System Penetration

Imran A. Nizamuddin, Narendranath Epperla, Mary-Kate Malacek, Brad S. Kahl, Fei Wan, Anne Fischer, Chaz Moreno, Emily R. King, Anna Krivenko, Nancy L. Bartlett, Neha Mehta-Shah
Journal: Blood
Blood (2024) 144 (Supplement 1): 985.
https://doi.org/10.1182/blood-2024-204521
Published: 2024
Journal Articles

The Predictive Value of Cell-of-Origin Subtype By Hans Algorithm in 718 Patients with Large B Cell Lymphoma Receiving Polatuzumab Vedotin

Edward R Scheffer Cliff, Guido D Pelaez, Fei Wan, Varun Iyengar, Jihao Zhou, Kevin Chung, Nayef Abdel-Razeq, Ajay Major, Jessica M Allen, John Sharp, Narendranath Epperla, Patrick Gould, Hua-Jay J Cherng, Samin Houshyar, Danielle S Wallace, Ryan C. Lynch, Avyakta Kallam, Matthew Mei, Reid W. Merryman, Michelle Fleyshman, Joanna M. Rhodes, Adam Kidwell, Timothy S Fenske, Erin Mulvey, Marcus P. Watkins, Muhamad Alhaj Moustafa, Talal Hilal, Grzegorz S. Nowakowski, Yucai Wang, Pallawi Torka, David A Russler-Germain
Journal: Blood
Blood (2024) 144 (Supplement 1): 652.
https://doi.org/10.1182/blood-2024-202153
Published: 2024
Journal Articles

The Impact of Tocilizumab Treatment for Cytokine Release Syndrome on the Incidence of Blood Stream Infections after Peripheral Blood Haploidentical Hematopoietic Cell Transplantation

Elisa De Togni, Fei Wan, Michael Slade, Ramzi Abboud
Journal: Blood
Blood (2021) 138 (Supplement 1): 1800.
https://doi.org/10.1182/blood-2021-147103
Published: 2021
Journal Articles

A Pilot Study of CPX-351 (Vyxeos © ) for Transplant Eligible, Higher Risk Patients with Myelodysplastic Syndrome

Meagan A. Jacoby, David A. Sallman, Bart L. Scott, Megan Haney, Fei Wan, John F. DiPersio, Ramzi Abboud, Keith E. Stockerl-Goldstein, Rami S. Komrokji, Mark A. Schroeder, Matthew J. Walter, Peter Westervelt, Geoffrey L. Uy
Journal: Blood
Blood (2021) 138 (Supplement 1): 540.
https://doi.org/10.1182/blood-2021-151137
Published: 2021
Journal Articles

End of Treatment Peripheral Blood TCR Evaluation for Minimal Residual Disease Evaluation in Peripheral T-Cell Lymphomas

Neha Mehta-Shah, Eric D Jacobsen, Todd A. Fehniger, Brad S. Kahl, Nancy L. Bartlett, Amanda F. Cashen, Armin Ghobadi, Beth Reagan, Anne Fischer, Alison J. Moskowitz, Fei Wan, Austin Jacobsen, Meredith Olson, Edgar Vigil, Natalie Hill, Karina Elias, Ying Huang, Steven M. Horwitz
Journal: Blood
Blood (2021) 138 (Supplement 1): 3506.
https://doi.org/10.1182/blood-2021-148768
Published: 2021
Journal Articles

BMI Is Not Associated with Toxicity to High Dose Methotrexate: A Single Institution Retrospective Study of 147 Patients

Shakthi Bhaskar, MD, Priyanka Pullarkat, Fei Wan, Sara Butler, Neha Mehta-Shah, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 42.
https://doi.org/10.1182/blood-2020-137536
Published: 2020
Journal Articles

End of Treatment Peripheral Blood T-Cell Receptor Gene Rearrangement Evaluation for Minimal Residual Disease Evaluation in Peripheral T-Cell Lymphomas

Neha Mehta-Shah, MD, Todd A Fehniger, MDPhD, Eric D Jacobsen, MD, Katrina Peterson, Brad S. Kahl, MD, Nancy L. Bartlett, MD, Amanda F Cashen, MD, Armin Ghobadi, MD, Anne Fischer, BS, Beth Reagan, Alison J. Moskowitz, MD, Fei Wan, Ying Huang, PhD, Kasey Hutt, PhD, Edgar Vigil, Meredith Olson, Austin Jacobsen, Steven M. Horwitz, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 30–31.
https://doi.org/10.1182/blood-2020-138768
Published: 2020
Journal Articles

A Pilot Study of Acalabrutinib with Bendamustine/Rituximab Followed By Cytarabine/Rituximab (R-ABC) for Untreated Mantle Cell Lymphoma

Daniel Guy, MD, Marcus Watkins, PhD, Fei Wan, Nancy L. Bartlett, MD, Amanda F Cashen, MD, Todd A Fehniger, MDPhD, Armin Ghobadi, MD, Neha Mehta-Shah, MD, Brad S. Kahl, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 8–9.
https://doi.org/10.1182/blood-2020-143095
Published: 2020